Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Statement of Cash Flows [Abstract]
Net earnings	$ 4,049	$ 9,373
Adjustments to reconcile net earnings to net cash from operating activities:
Depreciation	565	582
Amortization of intangible assets	6,057	5,728
Deferred income taxes	(1,498)	(1,415)
Change in fair value of contingent consideration liabilities	3,432	647
Payment for Contingent Consideration Liability, Operating Activities	(407)	(161)
Stock-based compensation	622	539
Acquired IPR&D and milestones	496	454
Gain on divestitures		(172)
Non-cash litigation reserve adjustments, net of cash payments	(205)	2,261
Impairment of Intangible Assets (Excluding Goodwill)	2,824	770
Other, net	(219)	(151)
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable	(273)	(1,039)
Inventories	(513)	(516)
Prepaid expenses and other assets	394	(60)
Accounts payable and other liabilities	3,661	491
Income tax assets and liabilities, net	(899)	184
Cash flows from operating activities	18,086	17,515
Cash flows from investing activities
Acquisitions and investments	(670)	(494)
Acquisitions of property and equipment	(572)	(482)
Purchases of investment securities	(43)	(1,428)
Sales and maturities of investment securities	41	1,460
Other, net	35	769
Cash flows from investing activities	(1,209)	(175)
Cash flows from financing activities
Proceeds from issuance of long-term debt	0	2,000
Repayments of long-term debt and finance lease obligations	(2,355)	(7,582)
Dividends paid	(7,913)	(7,537)
Purchases of treasury stock	(1,969)	(1,483)
Proceeds from the exercise of stock options	149	209
Payments of contingent consideration liabilities	(735)	(817)
Other, net	50	41
Cash flows from financing activities	(12,773)	(15,169)
Effect of exchange rate changes on cash and equivalents	(18)	(85)
Net change in cash and equivalents	4,086	2,086
Cash and equivalents, beginning of period	9,201	9,746
Cash and equivalents, end of period	$ 13,287	$ 11,832